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• Examination techniques employed such as positron
emission tomography (PET) or single-photon emission
computer tomography (SPECT) are also able to
illustrate tumor metabolism.
• The greatest challenge associated with the design of
novel radiolabeled compounds is the development of
the molecule for selective tissue targeting.
• Using diagnostic radiopharmaceuticals in multi-
modality imaging is beginning to gain widespread
application.
• It offers not only more accurate diagnosis, but also
facilitates personalized therapy and helps a better
understanding of the underlying pathological
processes.
Ideal therapeutic radiopharmaceuticals:
• Should locate at the tumor site,
• Producing minimal damage to normal surrounding
tissues
The design of radiopharmaceuticals requires
optimization between in vivo targeting of the tumor and
the clearance of radioactivity from non-target tissues.
